Revaprazan Uses, Dosage, Side Effects and more
Revaprazan is under investigation in clinical trial NCT01750437 (Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(nerd)).
| Trade Name | Revaprazan |
| Generic | Revaprazan |
| Revaprazan Other Names | Revaprazan, Yh-1885 free base |
| Type | |
| Formula | C22H23FN4 |
| Weight | Average: 362.452 Monoisotopic: 362.19067492 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
